• Tango Therapeutics said Executive Chair Barbara Weber’s employment ended on Aug. 3, 2026.
• Weber is deemed to have resigned from all officer roles and her board seat upon termination.
• The filing said her departure was not tied to any disagreement over the company’s operations, practices, or policies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-338480), on August 06, 2026, and is solely responsible for the information contained therein.